is tirzepatide as effective as ozempic vs. Semaglutide: Key Differences & Benefits Ozempic maker Novo Nordisk sues

The GLP-1 pathway provides the appetite suppression that most users notice first

Clinical trial results suggest that tirzepatide outperforms semaglutide, a sole GLP-1 receptor agonist, for controlling blood sugar and reducing weight

DePasquale also lists the following as situations where Medicaid may not cover Zepbound: Plan excludes anti-obesity meds entirely Patient doesnt meet prior authorization criteria (e.g., body mass index/comorbidity thresholds, recent participation in a structured lifestyle program) Contraindications (e.g., history of medullary thyroid carcinoma, multiple endocrine neoplasia Type 2, pregnancy, and lactation) Quantity or age limits How to get approved for Zepbound If your healthcare provider thinks Zepbound is the best medication to help with weight management, there are a few things you can do together to increase the chances of your Medicaid plan approving it for weight loss

What comes after it is a playbook